Original release date: April 29, 2020
Access to this course expires on: November 6, 2022 at 11:59 PM Pacific Time
Faculty: Charles Matthew Quick, MD, Carlos Parra-Herran, MD, Vinita Parkash, MBBS, MPH & Joseph T. Rabban, MD, MPH
- Appraise the new classification of endocervical glandular neoplasia which is based on etiology and biologic behavior.
- Recognize the pathologic spectrum and clinical importance of HPV-unrelated forms of endocervical adenocarcinoma.
- Identify the most critical changes in the 2018 FIGO update on staging of carcinoma the uterine cervix.